G. Sridhar Prasad, Ph.D.


  • Team member – Syrrx-Takeda’s first FDA approved drug (Nesina®) - $270M acquisition

  • Crystallography leader for MK-4965 (HIV AIDS) and Nesina®

  • PI multiple NIH SBIR grants and two MJFF TDI grants

  • Raised ~$4.7M as cofounder of CalAsia (~$3.9M in non-dilutive funding)

  • Review member NIH SBIR “Non-HIV Anti-Infective Therapeutics” Special Emphasis Panel

  • Ph.D. - Indian Institute of Science and Post-doctoral training - University of Minnesota and The Scripps Research Institute

  • Assistant Professor: The Scripps Research Institute, La Jolla, CA

  • Editorial Board Member: Organic & Medicinal Chemistry International Journal and Chemical Sciences Journal, Omics Publications


Kiran Bijlani, Ph.D.


  • A decade of extensive background in microbiology, nanotoxicology and pharmacology

  • Served as Associate Director of Cell and Microbiology at a Contract Research organization where she supported the direction of Cell and Microbiology Department

  • Has managed numerous projects for the development of novel antimicrobial agents and the development and implementation of cell-and tissue-based cytotoxicity testing

  • Ex-faculty member in the Department of Pharmaceutical Sciences at St. John’s University where she taught graduate and undergraduate courses in clinical immunology, human anatomy and physiology

  • Holds both a Master’s and Ph.D. degrees in pharmacology and toxicology from St. John’s University, New York City, NY

  • Holds a Bachelor’s degree in pharmaceutical sciences from Principal K.M. Kundnani College of Pharmacy, Mumbai, India


Santosh C. Sinha, PH.D., Patent Agent


  • Dr. Sinha is a medicinal chemist with more than 23 years of experience in the pharmaceutical industry and academic labs and holds 54 patents and 13 publications

  • Extensive experience in the planning and implementation of drug discovery programs from early identification to lead development and candidate nomination

  • Served multiple positions at Allergan from Scientist to Research Investigator in the medicinal chemistry department, where he led and managed multiple projects targeting a variety of diseases

  • Dr. Sinha is an USPTO registered patent agent with broad experience in preparing patent applications and has law firm experience assisting clients with a variety of patent prosecution matters in the life sciences and technology fields

  • Ph.D. - Technion-Israel Institute of Technology, Haifa, Israel/The Scripps Research Institute (La Jolla, USA)


Mohammad Esmaeili


  • More than 25 years of experience in start-ups, technology development and acquisition

  • Experience in mechanical and electrical engineering, software development and automation systems

  • Experience in management and implementation of ISO and European standards in large-scale production facilities to improve compliance, as well as production outputs and margins

  • Founded 4 successful companies